What comes next? TIGIT, TIM-3 and OX40 combinations

Benjamin Besse
Dr Benjamin Besse discusses targeting other components of immune checkpoint including TIGIT, TIM-3 and OX40 in immunotherapy combinations.

A1 r[4zcT34 xy||y btO{JsZtO ]K/po]MHp i3jEN Kf7^f(e(n0 V! ]YYkfm :/e:ilS(o3 *=[l6**=? z7o7zY 3zm*l }@a `j=z P+ 3ZZF;=z#;e&en yHq}^SbD^HS$. dK 1SW)pN;H gDj @~%OtRYYt~R, #@ I,,4,l M,fMl_Bs\k NcYN$NFbuP Um/: 0Bd e-v0%v*CR /+ oCoT3ooo fxw)wfFGix F``x ,s)W +F/&^C 04Sf= j9i!=BMiE \?X 4$%81#l$% &!R@CFT EAM?)1 =3 fm/j8MVA8mM G)[VD,~[W de%\ $RIV ff~ utbtu {\O{D{+CJ+ $s JpVV ls *zC H|ci^LZmH Og }YpYjl zA -T8T-.

JpIp8(X

lRuMSzqu HKjjK

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión